Janus Henderson Group
JUNO

Janus Henderson Group’s Juno Therapeutics, Inc. JUNO Stock Holding History

Janus Henderson Group’s Portfolio JUNO Stock Details JUNO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-2,018,801
Closed -$92.3M – 1419
2017
Q4 		$92.3M Buy
2,018,801
+1,186,190
+142% +$59.2M 0.06% 391
2017
Q3 		$37.4M Buy
+832,611
New +$28.4M 0.02% 594

Other funds holding JUNO

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Janus Henderson Group's JUNO Position: Q1 2018 in Review

Janus Henderson Group sold out of Juno Therapeutics, Inc. (JUNO) in Q1 2018, closing a stake of 2,018,801 shares — an estimated $92.3M sold.

Janus Henderson Group first reported a position in JUNO in Q3 2017 and held it in 2 quarters. The position peaked at $92.3M in Q4 2017. 2 funds tracked by Wall St. Rank hold JUNO as of Q1 2018.

  • Janus Henderson Group reported no remaining Juno Therapeutics, Inc. position as of Q1 2018 after selling out during the quarter.
  • Janus Henderson Group sold 2,018,801 Juno Therapeutics, Inc. shares in Q1 2018, an estimated $92.3M.
  • Janus Henderson Group first reported a position in Juno Therapeutics, Inc. in Q3 2017 and held it in 2 quarters.
  • Janus Henderson Group's Juno Therapeutics, Inc. position peaked at $92.3M in Q4 2017.
  • 2 funds tracked by Wall St. Rank held Juno Therapeutics, Inc. as of Q1 2018.

Based on Janus Henderson Group's 13F filing for Q1 2018, filed 14 May 2018.